site sponsored by
Tag Archive | "indications"
Tags: drug, dulera, green, indications, pfizer, Regulatory, regulatory-flag, university
Safety concerns force Pfizer to suspend pain trials
Posted on 24 June 2010
Posted in Top NewsComments (0)
Tags: article, blood-disorder, clinical-trials, crizotinib, diego-school, drug, dulera, indications, medicine, moores, pfizer, phase, promising
Pivotal test readied for Pfizer’s promising lung cancer drug
Posted on 23 June 2010
Posted in Top NewsComments (0)
Tags: asian, biotech, directors, gets-promising, improve-patient, indications, product, selling-noncore, stempeutics, the-product
Live From BIO 2010: A chat with Stempeutics
Posted on 06 May 2010
Posted in Top NewsComments (0)
Tags: arsalan-arif, bayer-health, biotech, biotechs-biogen, blockbuster, cellzome, drug, glaxosmithkline, haggling-over, indications, most-expensive, other-tangible, partnership, under-the-terms
Who’s the next biotech buyout target?
Posted on 09 March 2010
Posted in Top NewsComments (0)
Tags: akarx, ambit, biosciences, biotech, commonly, development, emerging-drug, europe, hematology, indications, japan, merck-serono, potential, the-development
Ambit strikes $390M deal with Astellas for lead drug
Posted on 18 December 2009
Posted in Top NewsComments (0)
Tags: biosciences, commonly, europe, hematology, indications, onrigin, potential, sales, says-it-doesn, work
Cash-strapped Vion files for bankruptcy
Posted on 18 December 2009
Posted in Top NewsComments (0)
Tags: biotech, drug, indications, marrow-the-way, months-longer, ogx-011, oncogenex, outlines-plans, scott-cormack, suppress-bone, trial-presented
OncoGenex hunts for prostate cancer drug partner
Posted on 05 August 2009
Posted in Top NewsComments (0)
Tags: biotech, bruce-beutler, drug, french, gilead-sciences, graham-lidgard, indications, novogen-limited, pharmaceuticals, reggie-bowerman, Regulatory, sciences, vice-president
Merck vaccines chief steps down
Posted on 05 August 2009
Posted in Top NewsComments (0)
Tags: afford-it-which, customers, DTC, facebook, fibromyalgia, indications, internet, Regulatory, research, Social Media, trade-magazine
Redirect URL’s: Much noise about nothing
Posted on 10 April 2009
Posted in DTCComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Design: Flash-banner-eyebrow nightmare
- Even After Patent Cliff, Pfizer Is Undervalued
- Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
- FTC: âTide May Be Turningâ On Pay-To-Delay Deals
- Celgene Beats and Raises Guidance
- Who is Killing the Pharmaceutical Sales Position?
- Snafi – HCP print ad in the UAE
- Hospira plans big study for new Epogen biosimilar
- New from OSI / Astellas
- Athersys buoyed by upbeat PhI stem cell data
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
